Ep. 89 - Califf's Passions, RWE in China & LSP Rising
2021-11-15
32 min
6 chapters
Available Results
Generated results are saved to the knowledge database for reuse and search.
No generated results are available for this episode yet.
Extract Knowledge
Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.
Generated results for public episodes are saved to the knowledge database so they can be reused and searched later.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
1. 8th Annual China Healthcare Summit: Kicks Off
2. Robert Califf's Likely Priorities at FDA
3. Bringing Down Real World Evidence Barriers In China
4. VC Focus: LSP set to get even bigger
5. Genenta Aims to Become First Italian Biotech to List in U.S.
6. Emerging Company Profile Spotlight: Alltrna, Marengo, GlycoEra, VelaVigo
8th Annual China Healthcare Summit: Kicks Off
59.0s
Robert Califf's Likely Priorities at FDA
303.0s
Bringing Down Real World Evidence Barriers In China
982.0s
VC Focus: LSP set to get even bigger
1267.0s
Genenta Aims to Become First Italian Biotech to List in U.S.
1570.0s
Emerging Company Profile Spotlight: Alltrna, Marengo, GlycoEra, VelaVigo
1666.0s